首页> 美国卫生研究院文献>Cardiology and Therapy >Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study

【2h】

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study

机译：日本非瓣膜性房颤患者抗凝治疗的特征：J-达比加群监测和JAPAF研究的描述性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionFollowing approval of dabigatran and other antithrombotics in Japan, few studies have specifically evaluated the clinical characteristics of patients prescribed these antithrombotics for nonvalvular atrial fibrillation (NVAF) in real-world practice.

机译：简介在日本批准达比加群和其他抗栓剂后，很少有研究专门评估在现实生活中将这些抗栓剂用于非瓣膜性心房颤动（NVAF）的患者的临床特征。

著录项

期刊名称 Cardiology and Therapy
作者
Yukihiro Koretsune; Koichi Kusakawa; Kouji H. Harada; Akio Koizumi; Shinichiro Uchiyama; Hirotsugu Atarashi; Ken Okumura; Masahiro Yasaka; Takeshi Yamashita; Atsushi Taniguchi; Taku Fukaya; Hiroshi Inoue;
展开▼
作者单位

展开▼
年(卷),期 2019(8),1
年度 2019
页码 43–54
总页数 12
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Anticoagulant Dabigatran Japan Nonvalvular atrial fibrillation Postmarketing surveillance;

机译：抗凝剂;日本达比加群;非瓣膜性房颤;上市后监测;

相似文献

外文文献
中文文献
专利

1. Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study [J] . Yukihiro Koretsune, Koichi Kusakawa, Kouji H. Harada, Cardiology and therapy. . 2019,第1期

机译：日本非瓣膜性房颤患者抗凝治疗的特征：J-达比加群监测和JAPAF研究的描述性分析
2. Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance [J] . Hiroshi Inoue, Shinichiro Uchiyama, Hirotsugu Atarashi, Journal of arrhythmia. . 2016,第2期

机译：日本非瓣膜性心房颤动患者长期使用达比加群的上市后监测：J-达比加群监测的初步报告
3. Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study) [J] . Koichi Kusakawa, Kouji H. Harada, Tatsuo Kagimura, Journal of arrhythmia. . 2017,第2期

机译：日本非瓣膜性房颤患者选择抗栓治疗的主要决定因素（JAPAF研究）
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Dabigatran versus warfarin for the prevention of stroke in patients with chronic nonvalvular atrial fibrillation. [D] . Qiu, Fen. 2011

机译：达比加群与华法林预防慢性非瓣膜性房颤患者的中风。
6. Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance [O] . Hiroshi Inoue, Shinichiro Uchiyama, Hirotsugu Atarashi, 2016

机译：日本非瓣膜性心房颤动患者长期使用达比加群的上市后监测：J-达比加群监测的初步报告
7. Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance [O] . Inoue Hiroshi, Uchiyama Shinichiro, Atarashi Hirotsugu, 2016

机译：日本非瓣膜性心房颤动患者长期使用达比加群的上市后监测：J-达比加群监测的初步报告

Characteristics of Japanese Patients with Nonvalvular Atrial Fibrillation on Anticoagulant Treatment: A Descriptive Analysis of J-dabigatran Surveillance and JAPAF Study

摘要

著录项

相似文献

相关主题

期刊订阅